课题基金 / 基金详情

项目摘要

项目成果

MICHAEL A. RUBIN的其他基金

相关文献

中文摘要
翻译
通过模拟和监测改进耐甲氧西林金黄色葡萄球菌控制 背景: 感染控制界对最合适的控制策略存在严重分歧。 耐甲氧西林金黄色葡萄球菌(MRSA)在医院的传播使用的一种方法 在退伍军人医院,将对所有患者进行监测测试,以识别和隔离MRSA携带者。 一种更有效和/或更具成本效益的替代方法将对 退伍军人事务部。我们之前的工作表明,一种对分类患者进行有针对性的监测的方法 因为使用电子数据携带MRSA的高风险可能是更实际的替代考虑 提供了一种监测MRSA的方法。鉴于对感染控制策略的大规模研究通常是 然而,困难和昂贵令人望而却步的是,使用详细计算机的替代方法 模拟可能为未来的研究工作提供重要的洞察力和方向。 目标: 对MRSA传播的控制依赖于无数因素和过程的相互作用, 尽管对这些相互作用或不同MRSA的相对有效性知之甚少 控制策略。考虑到这一点,我们的目标是(A)开发一种电子分类 在入院时识别携带MRSA的高危VA患者的算法;(B) 调整、校准和验证MRSA向退伍军人管理局传播的基于代理的计算机模拟 住院环境;(C)使用这种计算机模拟来更深入地了解 影响耐甲氧西林金黄色葡萄球菌在医院的传播和控制;以及(D)评估和比较替代方案 退伍军人医院控制耐甲氧西林金黄色葡萄球菌的政策,包括有针对性的监测,特别注重 评估这些不同战略的成本效益。 方法: 首先,我们将创建并验证电子分类规则,以评估MRSA在 入院时住院的退伍军人。该人群中MRSA携带率的预测因素为 通过使用我们合作中的电子数据进行的回溯性队列研究确定 弗吉尼亚州的网站。然后,我们将从我们的协作退伍军人管理局站点收集本地患者和设施级别的数据,以 使我们的模拟适应VA设置,并创建基本情况模拟场景。跟随 验证模型后,我们将评估影响MRSA的各种策略和因素 通过仿真实验进行传输。一项有针对性的主动监视战略将包括 将分类规则的性能融入到仿真中。传统数量型 将使用流行病学方法来分析模拟结果,重点是MRSA的流行率 和传播率作为结果。还将使用模拟成本进行成本效益分析 算出来了。
英文摘要
Improving MRSA control through simulation and surveillance BACKGROUND: The infection control community is highly divided on the most appropriate strategy to control transmission of methicilllin-resistant Staphylococcus aureus (MRSA) in hospitals. One approach used at VA hospitals is to perform surveillance testing on all patients to identify and isolate MRSA carriers. An alternative approach that is more efficient and/or cost-beneficial would be of tremendous value to the VA. Our previous work suggests that an approach using targeted surveillance of patients classified as high risk for MRSA carriage using electronic data may be a more practical alternative consideration for an approach to MRSA surveillance. Given that large studies of infection control strategies are often prohibitively difficult and expensive, however, an alternative approach using detailed computer simulations might provide important insight and direction for future research efforts. OBJECTIVES: Control of MRSA transmission is dependent on the interactions of innumerable factors and processes, although relatively little is known about these interactions or the relative effectiveness of different MRSA control strategies. With this in mind, our objectives are to (a) develop an electronic classification algorithm to identify VA patients at high risk of MRSA carriage at the time of hospital admission; (b) adapt, calibrate, and validate an agent-based computer simulation of MRSA transmission to the VA inpatient setting; (c) use this computer simulation to gain a deeper understanding of the factors that influence MRSA transmission and control in hospitals; and (d) evaluate and compare alternative policies for MRSA control in VA hospitals, including targeted surveillance, with a particular focus on assessing the cost-benefit of these different strategies. METHODS: First we will create and validate an electronic classification rule to estimate risk of MRSA carriage in hospitalized veterans at the time of admission. Predictors of MRSA carriage in this population will be determined through a retrospective cohort study performed using electronic data from our collaborating VA sites. We will then gather local patient- and facility-level data from our collaborating VA sites to adapt our simulation to the VA setting and to create a base-case simulation scenario. Following validation of the model, we will then assess the various strategies and factors that impact MRSA transmission through simulation experiments. A targeted active surveillance strategy will be included by incorporating the performance of our classification rule into the simulation. Traditional quantitative epidemiologic methods will be used to analyze simulation results, with a focus on MRSA prevalence and transmission rates as outcomes. Cost-benefit analyses will also be performed using simulated cost figures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART)
  • 批准号:
    10646169
  • 项目类别:
  • 资助金额:
    $73.72万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL A. RUBIN
  • 依托单位:
Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART)
  • 批准号:
    10466713
  • 项目类别:
  • 资助金额:
    $26.08万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL A. RUBIN
  • 依托单位:
Antimicrobial Use and Control of Clostridium difficile transmission and infection
Antimicrobial Use and Control of Clostridium difficile transmission and infection